newsfilter
← Latest News
Business Wire·

Xeris Biopharma Announces Private Exchange of Convertible Notes

Eliminates approximately $23 million of debt, resulting in approximately $2 million in annual interest savings Principal to be paid in cash, remainder in common stock Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a